新冠后患者的上颌毛霉菌病性骨髓炎：14例病例系列

Maxillary Mucormycosis Osteomyelitis in Post COVID-19 Patients: A Series of Fourteen Cases.

作者信息

Said Ahmed Wael M, Elsherbini Amira M, Elsherbiny Nehal M, El-Sherbiny Mohamed, Ramzy Nevine I, Arafa Ahmed F

机构信息

Oral and Maxillofacial Department, Faculty of Dentistry, Mansoura University, Mansoura 35516, Egypt.

Oral Biology Department, Faculty of Dentistry, Mansoura University, Mansoura 35516, Egypt.

出版信息

Diagnostics (Basel). 2021 Nov 5;11(11):2050. doi: 10.3390/diagnostics11112050.

During the current pandemic of COVID-19, numerous manifestations and complications have developed. Patients with COVID-19 are at high risk of fungal infections, such as mucormycosis, that may result directly from COVID-19 infection and/or as a side effect of the drugs used in COVID-19 treatment protocol, such as dexamethasone, hydroxychloroquine, and antibiotics. In this report, we described a series of 14 cases with maxillary mucormycosis osteomyelitis in immediate post-COVID-19 patients.